The effect of oral magnesium on glycemic and metabolic control in patients with type 1 diabetes

Phase 3

Recruiting

• Conditions: Type 1 diabetes.; Type 1 diabetes mellitus without complications; E10.9

• Registration Number: IRCT20221018056231N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Having type 1 diabetes
Age range from 6 to 18 years

Exclusion Criteria

History of sensitivity to magnesium compounds
Suffering from chronic diseases
Use of special medicine other than insulin
Use of compounds containing calcium

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood sugar. Timepoint: Before intervention and 6 months after taking magnesium supplement. Method of measurement: Blood test.;Glycosylated hemoglobin. Timepoint: Before intervention and 6 months after taking magnesium supplement. Method of measurement: Blood test.;High-density lipoprotein cholesterol (HDL). Timepoint: Before intervention and 6 months after taking magnesium supplement. Method of measurement: Blood test.;Low-density lipoprotein cholesterol (LDL). Timepoint: Before intervention and 6 months after taking magnesium supplement. Method of measurement: Blood test.;Body mass index(BMI). Timepoint: Before intervention and 6 months after taking magnesium supplement. Method of measurement: Meters and Clinic scales.